Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03033355 · ClinicalTrials.gov registry record
Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder
A clinical trial of Multiple Sclerosis and Lower Urinary Tract Symptoms, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT03033355 is a study of Multiple Sclerosis and Lower Urinary Tract Symptoms that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 12 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03033355, a study of Multiple Sclerosis and Lower Urinary Tract Symptoms, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate higher neural changes following intra-detrusor injection of Onabotulinumtoxin-A (BTX-A) in patients with Multiple Sclerosis (MS). We will use our prospectively collected cohort of patients. Concurrent Urodynamic and Functional Magnetic Resonance (fMRI) data will be recorded pre- and post-intravesical injection of BTX-A in patients with Multiple Sclerosis (MS) and neurogenic detrusor activity (NDO).
Conditions Studied
Interventions
- DRUG Intra-detrusor injection of Onabotulinumtoxin-A
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-02 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03033355
The ClinicalTrials.gov registry entry for NCT03033355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Intra-detrusor injection of Onabotulinumtoxin-A is the first listed.
NCT03033355 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03033355 about?
NCT03033355 is a clinical study titled "Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder". The purpose of this research study is to evaluate higher neural changes following intra-detrusor injection of Onabotulinumtoxin-A (BTX-A) in patients with Multiple Sclerosis (MS). We will use our prospectively collected cohort of patients. Concurrent Urodynamic and Functional Magnetic Resonance (fM...
What is the current status of trial NCT03033355?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-02. Estimated completion is 2019-03.
What conditions does trial NCT03033355 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Lower Urinary Tract Symptoms, Neurogenic Bladder, Urge Incontinence, Detrusor, Overactive.
What interventions are being tested in trial NCT03033355?
The interventions under investigation include: Intra-detrusor injection of Onabotulinumtoxin-A (DRUG).
Who is sponsoring clinical trial NCT03033355?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03033355 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.